Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Vitaspring Biomedical Co. Ltd. Stock Analysis VSBC
United States Health Care Nano Cap VitaSpring Biomedical Co. Ltd. engages in the research and development of stem cell applications in regenerative medicine and the establishment of advanced medical research centers and high standard cell production centers. The company is headquartered in Riverside, California and currently employs 0 full-time employees. The company went IPO on 2019-10-01. The firm invests in research and development of stem cell applications in regenerative medicine, establishes advanced medical research centers and cell production centers, and provides GTP standard stem cell preparations for the development of cellular drugs. The GTP Cell Center is the basis for its business, which is cross-domain in biotechnology medical treatment, medicine and medical materials, and focuses on the development of cell medical treatment. Its GTP standard stem cell production center is in Taipei, Taiwan for mass production of its mesenchymal stem cell (MSC), exesome, and cytopharmaceuticals. The company also cooperates with affiliated companies to support the mass production and commercialization of X.MSC-related medical projects.
Read More Vitaspring Biomedical Co. Ltd (VSBC) Chart
Key Statistics of Vitaspring Biomedical Co. Ltd (VSBC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.01Volume
408.00P/E Ratio (TTM)
-52 Week Range
Market Cap
2.30MAvg. Volume
4935.50Dividend Yield
-Financial Metrics & Statements of Vitaspring Biomedical Co. Ltd (VSBC)
FAQ's for Vitaspring Biomedical Co. Ltd (VSBC)
- According to Musaffa’s Shariah screening methodology, Vitaspring Biomedical Co. Ltd (VSBC) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Vitaspring Biomedical Co. Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Vitaspring Biomedical Co. Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Vitaspring Biomedical Co. Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Vitaspring Biomedical Co. Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Vitaspring Biomedical Co. Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.